Gyre Therapeutics, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
GYRE on Nasdaq
Industry
Pharmaceutical Preparations
Location
12770 High Bluff Drive, Suite 150, San Diego, CA

Insiders trading volume in the past year

Gyre Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GNI Group Ltd. 10%+ Owner $31.1M Oct 30, 2023
Songjiang Ma President, Director $28.2M -$1.3M -4.42% Mar 21, 2025
Ying Luo Director $1.33M Aug 14, 2024
Thomas Eastling Director $104K Apr 16, 2025
Nassim Usman Director $27.3K -$324K -92.2% Jun 28, 2024
Eddie Williams Director $16.4K Jan 7, 2022
Geoffrey M.D. Ling Director $14.9K Jan 7, 2022
Errol B. Desouza Director $14K Oct 1, 2021
Howard Levy Chief Medical Officer $11.3K Aug 9, 2021
Grant E. Blouse Chief Scientific Officer $4.43K Aug 9, 2022
E. Seline Miller SVP Finance; Interim CFO & PAO Aug 31, 2023
Andrea Hunt Director Aug 31, 2023
GNI Hong Kong Ltd 10%+ Owner Oct 27, 2023
Augustine Lawlor Director Aug 31, 2023
Sharon Tetlow Director Jun 9, 2021
Jeanne Y. Jew Director Sep 9, 2021
Charles C. Wu Chief Executive Officer, Director Nov 20, 2023
Renate Parry Director Aug 14, 2024
Gordon Carmichael Director Aug 14, 2024
Ruoyu Chen Chief Financial Officer Aug 14, 2024
Han Ying Chief Executive Officer, Director Aug 14, 2024
Ping Zhang Director Jan 5, 2025
David M. Epstein Director Aug 14, 2024
Weiguo Ye Chief Operating Officer Mar 7, 2025
Rodney Nussbaum Director Aug 14, 2024

Recent Insider Transactions by Companies or Individuals for Gyre Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.